The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Live Cholera Vaccines Market Research Report 2025
Synopsis
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
The global Oral Live Cholera Vaccines market was valued at US$ 85 million in 2023 and is anticipated to reach US$ 143.7 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
This report aims to provide a comprehensive presentation of the global market for Oral Live Cholera Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Live Cholera Vaccines.
Report Scope
The Oral Live Cholera Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Live Cholera Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Live Cholera Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech
Segment by Type
Euvichol- Plus
DUKORAL
Shanchol
Others
Segment by Application
Prevention
Emergency Response
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Live Cholera Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines.
The global Oral Live Cholera Vaccines market was valued at US$ 85 million in 2023 and is anticipated to reach US$ 143.7 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Factors such as increasing incidence of cholera outbreaks, rising awareness about the disease and its prevention, and government initiatives to control cholera are driving market growth. Oral live cholera vaccines offer advantages such as ease of administration, cost-effectiveness, and potential for herd immunity. The market is characterized by the presence of both established pharmaceutical companies and emerging players. However, challenges such as vaccine storage and distribution requirements, limited accessibility in resource-constrained regions, and the need for cold chain maintenance may pose obstacles to market expansion.
This report aims to provide a comprehensive presentation of the global market for Oral Live Cholera Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Live Cholera Vaccines.
Report Scope
The Oral Live Cholera Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Live Cholera Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Live Cholera Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PaxVax
Sanofi
Valneva
EuBiologics
Shanghai United Cell Biotechnology
Vabiotech
Segment by Type
Euvichol- Plus
DUKORAL
Shanchol
Others
Segment by Application
Prevention
Emergency Response
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Live Cholera Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Live Cholera Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Oral Live Cholera Vaccines Market Overview
1.1 Product Overview and Scope of Oral Live Cholera Vaccines
1.2 Oral Live Cholera Vaccines Segment by Type
1.2.1 Global Oral Live Cholera Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Euvichol- Plus
1.2.3 DUKORAL
1.2.4 Shanchol
1.2.5 Others
1.3 Oral Live Cholera Vaccines Segment by Application
1.3.1 Global Oral Live Cholera Vaccines Market Value by Application: (2024-2030)
1.3.2 Prevention
1.3.3 Emergency Response
1.4 Global Oral Live Cholera Vaccines Market Size Estimates and Forecasts
1.4.1 Global Oral Live Cholera Vaccines Revenue 2019-2030
1.4.2 Global Oral Live Cholera Vaccines Sales 2019-2030
1.4.3 Global Oral Live Cholera Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Live Cholera Vaccines Market Competition by Manufacturers
2.1 Global Oral Live Cholera Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Live Cholera Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Live Cholera Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Oral Live Cholera Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Live Cholera Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Live Cholera Vaccines, Product Type & Application
2.7 Oral Live Cholera Vaccines Market Competitive Situation and Trends
2.7.1 Oral Live Cholera Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Live Cholera Vaccines Players Market Share by Revenue
2.7.3 Global Oral Live Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Live Cholera Vaccines Retrospective Market Scenario by Region
3.1 Global Oral Live Cholera Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Live Cholera Vaccines Global Oral Live Cholera Vaccines Sales by Region: 2019-2030
3.2.1 Global Oral Live Cholera Vaccines Sales by Region: 2019-2024
3.2.2 Global Oral Live Cholera Vaccines Sales by Region: 2025-2030
3.3 Global Oral Live Cholera Vaccines Global Oral Live Cholera Vaccines Revenue by Region: 2019-2030
3.3.1 Global Oral Live Cholera Vaccines Revenue by Region: 2019-2024
3.3.2 Global Oral Live Cholera Vaccines Revenue by Region: 2025-2030
3.4 North America Oral Live Cholera Vaccines Market Facts & Figures by Country
3.4.1 North America Oral Live Cholera Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Live Cholera Vaccines Sales by Country (2019-2030)
3.4.3 North America Oral Live Cholera Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Oral Live Cholera Vaccines Market Facts & Figures by Country
3.5.1 Europe Oral Live Cholera Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Live Cholera Vaccines Sales by Country (2019-2030)
3.5.3 Europe Oral Live Cholera Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Live Cholera Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Live Cholera Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Live Cholera Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Live Cholera Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral Live Cholera Vaccines Market Facts & Figures by Country
3.7.1 Latin America Oral Live Cholera Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Live Cholera Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Oral Live Cholera Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Live Cholera Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Live Cholera Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Live Cholera Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Live Cholera Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Live Cholera Vaccines Sales by Type (2019-2030)
4.1.1 Global Oral Live Cholera Vaccines Sales by Type (2019-2024)
4.1.2 Global Oral Live Cholera Vaccines Sales by Type (2025-2030)
4.1.3 Global Oral Live Cholera Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Oral Live Cholera Vaccines Revenue by Type (2019-2030)
4.2.1 Global Oral Live Cholera Vaccines Revenue by Type (2019-2024)
4.2.2 Global Oral Live Cholera Vaccines Revenue by Type (2025-2030)
4.2.3 Global Oral Live Cholera Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Oral Live Cholera Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Live Cholera Vaccines Sales by Application (2019-2030)
5.1.1 Global Oral Live Cholera Vaccines Sales by Application (2019-2024)
5.1.2 Global Oral Live Cholera Vaccines Sales by Application (2025-2030)
5.1.3 Global Oral Live Cholera Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Oral Live Cholera Vaccines Revenue by Application (2019-2030)
5.2.1 Global Oral Live Cholera Vaccines Revenue by Application (2019-2024)
5.2.2 Global Oral Live Cholera Vaccines Revenue by Application (2025-2030)
5.2.3 Global Oral Live Cholera Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Oral Live Cholera Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 PaxVax
6.1.1 PaxVax Corporation Information
6.1.2 PaxVax Description and Business Overview
6.1.3 PaxVax Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 PaxVax Oral Live Cholera Vaccines Product Portfolio
6.1.5 PaxVax Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Oral Live Cholera Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Valneva
6.3.1 Valneva Corporation Information
6.3.2 Valneva Description and Business Overview
6.3.3 Valneva Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Valneva Oral Live Cholera Vaccines Product Portfolio
6.3.5 Valneva Recent Developments/Updates
6.4 EuBiologics
6.4.1 EuBiologics Corporation Information
6.4.2 EuBiologics Description and Business Overview
6.4.3 EuBiologics Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EuBiologics Oral Live Cholera Vaccines Product Portfolio
6.4.5 EuBiologics Recent Developments/Updates
6.5 Shanghai United Cell Biotechnology
6.5.1 Shanghai United Cell Biotechnology Corporation Information
6.5.2 Shanghai United Cell Biotechnology Description and Business Overview
6.5.3 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai United Cell Biotechnology Oral Live Cholera Vaccines Product Portfolio
6.5.5 Shanghai United Cell Biotechnology Recent Developments/Updates
6.6 Vabiotech
6.6.1 Vabiotech Corporation Information
6.6.2 Vabiotech Description and Business Overview
6.6.3 Vabiotech Oral Live Cholera Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vabiotech Oral Live Cholera Vaccines Product Portfolio
6.6.5 Vabiotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Live Cholera Vaccines Industry Chain Analysis
7.2 Oral Live Cholera Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Live Cholera Vaccines Production Mode & Process
7.4 Oral Live Cholera Vaccines Sales and Marketing
7.4.1 Oral Live Cholera Vaccines Sales Channels
7.4.2 Oral Live Cholera Vaccines Distributors
7.5 Oral Live Cholera Vaccines Customers
8 Oral Live Cholera Vaccines Market Dynamics
8.1 Oral Live Cholera Vaccines Industry Trends
8.2 Oral Live Cholera Vaccines Market Drivers
8.3 Oral Live Cholera Vaccines Market Challenges
8.4 Oral Live Cholera Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
